Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances.
作者信息
Alexis Andrew F, Blackcloud Paul
机构信息
Dr. Alexis is from the Skin of Color Center, Mount Sinai St. Luke's Roosevelt Hospital, New York, New York, and the Icahn School of Medicine at Mount Sinai, New York, New York. Mr. Blackcloud is from the Columbia University College of Physicians and Surgeons, New York, New York.
出版信息
J Clin Aesthet Dermatol. 2014 Nov;7(11):16-24.
Abstract
摘要
相似文献
1
Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances.有色人种皮肤中的银屑病：流行病学、遗传学、临床表现及治疗细微差别。
J Clin Aesthet Dermatol. 2014 Nov;7(11):16-24.
2
Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups.肤色性银屑病：非白种人种族/族群的银屑病流行病学、临床表现、遗传学、生活质量影响和治疗的见解。
Am J Clin Dermatol. 2018 Jun;19(3):405-423. doi: 10.1007/s40257-017-0332-7.
3
Author Correction to: Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups.作者对《有色人种皮肤中的银屑病：非白种种族/族裔群体中银屑病的流行病学、临床表现、遗传学、生活质量影响及治疗的见解》的勘误
Am J Clin Dermatol. 2018 Jun;19(3):425. doi: 10.1007/s40257-018-0347-8.
4
Psoriasis in patients of color: differences in morphology, clinical presentation, and treatment.有色人种患者的银屑病：形态学、临床表现和治疗的差异。
Cutis. 2020 Aug;106(2S):7-10;E10. doi: 10.12788/cutis.0038.
5
Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour.皮肤病学：如何管理银屑病以及识别有色人种患者在病理生理学和临床表现方面的差异。
Drugs Context. 2022 May 31;11. doi: 10.7573/dic.2021-9-3. eCollection 2022.
6
Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States.加拿大和美国银屑病及有色人种皮肤患者中未满足的需求。
Dermatol Ther (Heidelb). 2022 Nov;12(11):2401-2413. doi: 10.1007/s13555-022-00811-0. Epub 2022 Sep 21.
7
Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis.银屑病光化学疗法（PUVA）治疗期间皮损部位及对照部位皮肤血流和颜色的变化。
J Am Acad Dermatol. 2001 Jun;44(6):987-94. doi: 10.1067/mjd.2001.113459.
8
[Pustular psoriasis].[脓疱型银屑病]
Hautarzt. 2016 Jun;67(6):445-53. doi: 10.1007/s00105-016-3804-4.
9
Automatic Scale Severity Assessment Method in Psoriasis Skin Images Using Local Descriptors.基于局部描述子的银屑病皮肤图像自动严重程度评估方法。
IEEE J Biomed Health Inform. 2020 Feb;24(2):577-585. doi: 10.1109/JBHI.2019.2910883. Epub 2019 Apr 15.
10
Computer-aided diagnosis of psoriasis skin images with HOS, texture and color features: A first comparative study of its kind.基于 HOS、纹理和颜色特征的银屑病皮肤图像计算机辅助诊断：同类研究中的首次比较。
Comput Methods Programs Biomed. 2016 Apr;126:98-109. doi: 10.1016/j.cmpb.2015.11.013. Epub 2016 Jan 20.
引用本文的文献
1
Narrowband-Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color: A Systematic Review and Meta-Analysis.窄谱中波紫外线光疗治疗有色人种皮肤银屑病：一项系统评价和荟萃分析。
Photodermatol Photoimmunol Photomed. 2025 Sep;41(5):e70051. doi: 10.1111/phpp.70051.
2
Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global Study.美国银屑病患者的疾病体验：银屑病及其他全球研究结果
Drugs Real World Outcomes. 2025 Aug 29. doi: 10.1007/s40801-025-00499-6.
3
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.古塞库单抗用于治疗各种肤色的中度至重度银屑病：VISIBLE随机临床试验的A队列
JAMA Dermatol. 2025 Jun 25. doi: 10.1001/jamadermatol.2025.1836.
4
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.古塞库单抗用于治疗所有肤色的中度至重度头皮银屑病：VISIBLE随机临床试验的队列B
JAMA Dermatol. 2025 Jun 25. doi: 10.1001/jamadermatol.2025.1849.
5
Management of Challenging Psoriasis Clinical Scenarios.复杂银屑病临床病例的管理
Dermatol Ther (Heidelb). 2025 Jun;15(6):1555-1567. doi: 10.1007/s13555-025-01393-3. Epub 2025 Apr 15.
6
High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).斑块状银屑病的高系统性疾病风险与治疗延迟：英国皮肤科医师协会生物制剂和免疫调节剂登记处（BADBIR）中阿普米拉斯使用情况的回顾性分析
Dermatol Ther (Heidelb). 2025 Apr;15(4):903-918. doi: 10.1007/s13555-025-01358-6. Epub 2025 Mar 13.
7
IL-1 signaling enrichment in inflammatory skin disease loci with higher-risk allele frequencies in African ancestry.在非洲血统中具有较高风险等位基因频率的炎症性皮肤病基因座中白细胞介素-1信号富集。
Res Sq. 2025 Jan 23:rs.3.rs-5724270. doi: 10.21203/rs.3.rs-5724270/v1.
8
Inflammatory Nail Disorders in Skin of Color: A Systematic Review of Clinical and Onychoscopic Manifestations.有色人种皮肤中的炎症性甲病：临床和甲镜表现的系统评价
Int J Dermatol. 2025 Jun;64(6):1013-1020. doi: 10.1111/ijd.17680. Epub 2025 Feb 11.
9
A large-scale analysis of racial disparities in management of psoriatic disease.银屑病疾病管理中种族差异的大规模分析。
Arch Dermatol Res. 2025 Feb 4;317(1):339. doi: 10.1007/s00403-025-03904-w.
10
Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensus.优化有色人种银屑病患者的管理：加拿大德尔菲共识。
JAAD Int. 2024 Nov 14;19:12-20. doi: 10.1016/j.jdin.2024.09.015. eCollection 2025 Apr.
本文引用的文献
1
Differing effects of metformin on glycemic control by race-ethnicity.二甲双胍对不同种族-民族血糖控制的不同影响。
J Clin Endocrinol Metab. 2014 Sep;99(9):3160-8. doi: 10.1210/jc.2014-1539. Epub 2014 Jun 12.
2
Psoriasis prevalence among adults in the United States.美国成年人银屑病患病率。
J Am Acad Dermatol. 2014 Mar;70(3):512-6. doi: 10.1016/j.jaad.2013.11.013. Epub 2014 Jan 2.
3
Research gaps in psoriasis: opportunities for future studies.银屑病研究中的空白点：未来研究的机会。
J Am Acad Dermatol. 2014 Jan;70(1):146-67. doi: 10.1016/j.jaad.2013.08.042. Epub 2013 Oct 11.
4
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.白细胞介素-17 和肿瘤坏死因子协同调节细胞因子表达，同时抑制黑色素生成：与银屑病的潜在相关性。
J Invest Dermatol. 2013 Dec;133(12):2741-2752. doi: 10.1038/jid.2013.237. Epub 2013 Apr 30.
5
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.全球银屑病流行病学：发病率和患病率的系统评价。
J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27.
6
Psoriasis in African-Americans: a caregivers' survey.非裔美国人的银屑病：一项护理人员调查。
J Drugs Dermatol. 2012 Apr;11(4):478-82.
7
Top dermatologic conditions in patients of color: an analysis of nationally representative data.有色人种患者的常见皮肤病：基于全国代表性数据的分析
J Drugs Dermatol. 2012 Apr;11(4):466-73.
8
Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.白细胞介素-10 多态性与银屑病易感性的关联：荟萃分析。
Inflamm Res. 2012 Jul;61(7):657-63. doi: 10.1007/s00011-012-0458-2. Epub 2012 Mar 18.
9
HLA Antigens in Omani Psoriasis Vulgaris Patients.阿曼寻常型银屑病患者的人类白细胞抗原
Oman Med J. 2009 Jan;24(1):27-9. doi: 10.5001/omj.2009.7.
10
Role of phototherapy in patients with skin of color.光疗在有色人种皮肤患者中的作用。
Semin Cutan Med Surg. 2011 Dec;30(4):184-9. doi: 10.1016/j.sder.2011.08.007.
Zotero 插件